Retrospective analysis of wound characteristics and tetanus development in captive macaques
- PMID: 19368246
- PMCID: PMC3409561
- DOI: 10.1638/2008-0055.1
Retrospective analysis of wound characteristics and tetanus development in captive macaques
Abstract
Traumatic wounds and access to outdoor enclosures containing soil contribute to development of tetanus in nonhuman primates. A retrospective, matched case-control study was conducted at a primate center to evaluate these factors by analysis of medical records of animals sustaining traumatic injuries during a 3-yr study period. Thirty-one macaques with traumatic injuries and a clinical diagnosis of tetanus were selected as cases, and 62 macaques with traumatic injuries and no diagnosis of tetanus were selected as controls. For an animal with injuries to the digits, the odds of developing tetanus were 9.6 times those of a similar animal without injuries to the digits (Odds Ratio [OR] = 9.55, 95% CI = 1.56-58.59); with injuries to the tail, the odds of developing tetanus were 8.0 times those of a similar animal without injuries to the tail (OR = 7.95, 95% CI = 0.82-77.04); and with injuries in more than one location, the odds of developing tetanus were 8.5 times those for a similar animal with injuries in just one location (OR = 8.45, 95% CI = 1.01-70.46). A nonhuman primate with injuries to the leg was less likely to develop tetanus than a similar nonhuman primate without injuries to the leg (OR = 0.19, 95% CI = 0.03-1.2). Results indicated that wound location is associated with development of tetanus infection in rhesus macaques. Identification of high-risk trauma cases will allow better allocation of wound management and tetanus prophylaxis in institutions, especially in those housing nonhuman primates outdoors.
References
-
- Ananworanich J, Nuesch R, Teeratakulpisarn S, Srasuebkul P, Chuenyam T, Siangphoe U, Ungsedhaphand C, Phanuphak P, Ruxrungtham K. Letters to the editor. In vivo cell-mediated immunity in subjects with undetectable viral load on protease inhibitor-based versus non-protease inhibitor-based highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2003;32:570–573. - PubMed
-
- Aydin K, Caylan R, Caylan R, Bektas D, Koksal I. Otolaryngologic aspects of tetanus. Eur Arch Otorhinolaryngol. 2003;260:52–56. - PubMed
-
- Bernstein LJ, Ochs HD, Wedgwood RJ, Rubinstein A. Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr. 1985;107:352–257. - PubMed
-
- Bhatia R, Prabhakar S, Grover VK. Tetanus. Neurol India. 2002;50:398–407. - PubMed
-
- Borleffs JCC, Schuurman H-J, Vrehen HM, Van Schaik M, Bast EJEG. In vitro and in vivo measurement of cell-mediated immunity in patients with HIV-1 infection. Scand J Immunol. 1993;37:634–636. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
